BRCA1 and melanoma: These inconsistent data were most likely caused by biases; indeed, in some studies, not all patients in the BRCA cohort were genetically tested (4); contrariwise, the studies that detectedthe occurrence of BRCA1/2 mutations in patients with a history of melanoma were mainly underpowered and demonstrated large variability in terms of genetic mutations and ethnic populations (4, 5).